investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targets for Therapy for Carcinomas of the Lung
Mark G. Kris
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Mark G. Kris
Memorial Sloan Kettering Cancer Center
New York, United States
Related projects
Philip N. Tsichlis
Differential regulation of RNA processing by Akt isoforms
Trachea, bronchus and lung
Pathology
James K Chen
Chemical genetic dissection of Hipk4-dependent Hedgehog pathway activation
Trachea, bronchus and lung
Matthew L. Meyerson
Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma
Trachea, bronchus and lung
Tyshia Kyree Gwin
Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein
Trachea, bronchus and lung
Deborah Morrison
Role of Protein Scaffolds in RTK/Ras-Dependent Signal Transduction
Trachea, bronchus and lung
Ji Ming Wang
Role of Formylpeptide Receptors in Host Defense
Trachea, bronchus and lung
Joseph R Testa
RIP1/3 Kinases as New Targets in Malignant Mesothelioma
Trachea, bronchus and lung
Pathology
Nathanael Schiander Gray
Development of covalent PIP4K2 inhibitors for the treatment of p53 deficient lung tumors
Trachea, bronchus and lung
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Trachea, bronchus and lung